Formulation: A crystalline solid

Purity: ≥98%

• Gypenoside III
• NSC 310103

Formulation: A crystalline solid

Purity: ≥98%

• IL-1 Receptor-associated Kinase 1/4 Inhibitor
• Interleukin-1 Receptor-associated Kinase 1/4 Inhibitor

Formulation: A crystalline solid

Purity: ≥95%

• Ginsenoside Compound K
• Ginsenoside IH901

Formulation: A solid

Purity: ≥98%

• Interleukin-1 Receptor-associated Kinase 4 Inhibitor
• IL-1 Receptor-associated Kinase 4 Inhibitor
• IRAK4 Inhibitor

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

• IL-1 Receptor-associated Kinase 4 Inhibitor 1
• Interleukin-1 Receptor-associated Kinase 4 Inhibitor 1
• IRAK-IN-1

Formulation: A solid

Purity: ≥98%

• CA-4948

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

• IL-1 Receptor-associated Kinase 4 Inhibitor 6
• Interleukin-1 Receptor-associated Kinase 4 Inhibitor 6

Formulation: A solid

Purity: ≥98%

• IL-1 Receptor-associated Kinase 4 Inhibitor 1
• Interleukin-1 Receptor-associated Kinase 4 Inhibitor 1
• IRAK4-IN-1

Formulation: A solid

Purity: ≥95%

• IL-1 Receptor-associated Kinase 4 Inhibitor 28
• Interleukin-1 Receptor-associated Kinase 4 Inhibitor 28
• IRAK-IN-28

Formulation: A solid

Purity: ≥98%

• GS-5718

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

• NX-125

Formulation: A solid

Purity: ≥95%

• WIN 35,213

Formulation: A solid

Purity: ≥98%

• Lemur Tyrosine Kinase-IN-C28
• Lemur Tyrosine Kinase 3 Inhibitor 1
• Lemur Tyrosine Kinase Inhibitor C28
• LMTK3-IN-1
• LMTK3-IN-C28
• LMTK3 Inhibitor 1